RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other r… Read more
RadNet Inc (RDNT) - Net Assets
Latest net assets as of December 2025: $1.36 Billion USD
Based on the latest financial reports, RadNet Inc (RDNT) has net assets worth $1.36 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.76 Billion) and total liabilities ($2.40 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.36 Billion |
| % of Total Assets | 36.07% |
| Annual Growth Rate | N/A |
| 5-Year Change | 291.7% |
| 10-Year Change | 2504.82% |
| Growth Volatility | 110.04 |
RadNet Inc - Net Assets Trend (1995–2025)
This chart illustrates how RadNet Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RadNet Inc (1995–2025)
The table below shows the annual net assets of RadNet Inc from 1995 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.36 Billion | +19.63% |
| 2024-12-31 | $1.13 Billion | +39.35% |
| 2023-12-31 | $813.36 Million | +65.50% |
| 2022-12-31 | $491.45 Million | +41.97% |
| 2021-12-31 | $346.16 Million | +34.01% |
| 2020-12-31 | $258.30 Million | +10.79% |
| 2019-12-31 | $233.14 Million | +16.42% |
| 2018-12-31 | $200.25 Million | +186.38% |
| 2017-12-31 | $69.92 Million | +34.33% |
| 2016-12-31 | $52.05 Million | +42.76% |
| 2015-12-31 | $36.46 Million | +373.64% |
| 2014-12-31 | $7.70 Million | +248.33% |
| 2013-12-31 | $2.21 Million | +210.44% |
| 2012-12-31 | $-2.00 Million | +97.13% |
| 2011-12-31 | $-69.81 Million | +15.36% |
| 2010-12-31 | $-82.47 Million | -10.32% |
| 2009-12-31 | $-74.76 Million | +7.74% |
| 2008-12-31 | $-81.03 Million | -16.38% |
| 2007-12-31 | $-69.62 Million | +11.64% |
| 2006-12-31 | $-78.79 Million | -11.55% |
| 2005-12-31 | $-70.63 Million | -1.26% |
| 2004-12-31 | $-69.75 Million | -32.99% |
| 2003-12-31 | $-52.45 Million | -6.14% |
| 2002-12-31 | $-49.42 Million | -11.05% |
| 2001-12-31 | $-44.50 Million | +24.96% |
| 2000-12-31 | $-59.30 Million | +7.05% |
| 1999-12-31 | $-63.80 Million | -16.67% |
| 1998-12-31 | $-54.68 Million | -132.71% |
| 1997-12-31 | $-23.50 Million | +0.10% |
| 1996-12-31 | $-23.52 Million | -65.43% |
| 1995-12-31 | $-14.22 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to RadNet Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1960693800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $8.00K | 0.00% |
| Other Comprehensive Income | $4.88 Million | 0.45% |
| Other Components | $1.18 Billion | 108.31% |
| Total Equity | $1.09 Billion | 100.00% |
RadNet Inc Competitors by Market Cap
The table below lists competitors of RadNet Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Avionics Systems Co Ltd
SHG:600372
|
$4.19 Billion |
|
Hubei Dinglong Chemical
SHE:300054
|
$4.19 Billion |
|
Qube Holdings Limited
PINK:QUBHF
|
$4.20 Billion |
|
Duolingo Inc
NASDAQ:DUOL
|
$4.20 Billion |
|
Yang Ming Marine Transport Corp
TW:2609
|
$4.18 Billion |
|
PHILLIPS EDISON DL -01
F:9R4
|
$4.18 Billion |
|
CommScope Holding Co Inc
NASDAQ:COMM
|
$4.18 Billion |
|
Darktrace plc
PINK:DRKTY
|
$4.18 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RadNet Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 902,308,000 to 1,089,890,000, a change of 187,582,000 (20.8%).
- Net loss of 18,652,000 reduced equity.
- Other comprehensive income increased equity by 13,946,000.
- Other factors increased equity by 192,288,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-18.65 Million | -1.71% |
| Other Comprehensive Income | $13.95 Million | +1.28% |
| Other Changes | $192.29 Million | +17.64% |
| Total Change | $- | 20.79% |
Book Value vs Market Value Analysis
This analysis compares RadNet Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $-0.76 | $63.63 | x |
| 1996-12-31 | $-1.27 | $63.63 | x |
| 1997-12-31 | $-1.28 | $63.63 | x |
| 1998-12-31 | $-2.83 | $63.63 | x |
| 1999-12-31 | $-3.29 | $63.63 | x |
| 2000-12-31 | $-3.01 | $63.63 | x |
| 2001-12-31 | $-2.07 | $63.63 | x |
| 2002-12-31 | $-2.49 | $63.63 | x |
| 2003-12-31 | $-2.58 | $63.63 | x |
| 2004-12-31 | $-3.41 | $63.63 | x |
| 2005-12-31 | $-3.43 | $63.63 | x |
| 2006-12-31 | $-3.75 | $63.63 | x |
| 2007-12-31 | $-2.02 | $63.63 | x |
| 2008-12-31 | $-2.27 | $63.63 | x |
| 2009-12-31 | $-2.08 | $63.63 | x |
| 2010-12-31 | $-2.24 | $63.63 | x |
| 2011-12-31 | $-1.82 | $63.63 | x |
| 2012-12-31 | $-0.07 | $63.63 | x |
| 2013-12-31 | $0.00 | $63.63 | x |
| 2014-12-31 | $0.12 | $63.63 | x |
| 2015-12-31 | $0.72 | $63.63 | x |
| 2016-12-31 | $1.04 | $63.63 | x |
| 2017-12-31 | $1.30 | $63.63 | x |
| 2018-12-31 | $2.61 | $63.63 | x |
| 2019-12-31 | $3.02 | $63.63 | x |
| 2020-12-31 | $3.26 | $63.63 | x |
| 2021-12-31 | $4.28 | $63.63 | x |
| 2022-12-31 | $5.81 | $63.63 | x |
| 2023-12-31 | $9.75 | $63.63 | x |
| 2024-12-31 | $12.07 | $63.63 | x |
| 2025-12-31 | $14.50 | $63.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RadNet Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.91%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 3.45x
- Recent ROE (-1.71%) is below the historical average (3.34%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 0.00% | -135.47% | 0.68x | 0.00x | $-59.90 Million |
| 1996 | 0.00% | -14.79% | 0.53x | 0.00x | $-5.87 Million |
| 1997 | 0.00% | -1.12% | 0.78x | 0.00x | $1.74 Million |
| 1998 | 0.00% | -49.85% | 0.94x | 0.00x | $-23.79 Million |
| 1999 | 0.00% | -12.45% | 1.00x | 0.00x | $-2.58 Million |
| 2000 | 0.00% | 2.97% | 0.96x | 0.00x | $8.60 Million |
| 2001 | 0.00% | 12.97% | 0.87x | 0.00x | $19.07 Million |
| 2002 | 0.00% | -3.99% | 0.92x | 0.00x | $-458.90K |
| 2003 | 0.00% | -1.62% | 0.99x | 0.00x | $3.04 Million |
| 2004 | 0.00% | -10.62% | 1.09x | 0.00x | $-7.60 Million |
| 2005 | 0.00% | -2.15% | 1.20x | 0.00x | $3.93 Million |
| 2006 | 0.00% | -4.28% | 1.23x | 0.00x | $985.40K |
| 2007 | 0.00% | -4.26% | 0.98x | 0.00x | $-11.15 Million |
| 2008 | 0.00% | -2.56% | 1.01x | 0.00x | $-4.73 Million |
| 2009 | 0.00% | -0.43% | 1.09x | 0.00x | $5.21 Million |
| 2010 | 0.00% | -2.34% | 1.02x | 0.00x | $-4.60 Million |
| 2011 | 0.00% | 1.17% | 1.00x | 0.00x | $14.31 Million |
| 2012 | 0.00% | 9.97% | 0.90x | 0.00x | $64.78 Million |
| 2013 | 0.00% | 0.30% | 0.97x | 0.00x | $2.13 Million |
| 2014 | 25.66% | 0.19% | 0.97x | 138.14x | $839.80K |
| 2015 | 23.66% | 0.95% | 0.97x | 25.74x | $4.45 Million |
| 2016 | 14.91% | 0.82% | 1.04x | 17.52x | $2.38 Million |
| 2017 | 0.09% | 0.01% | 1.06x | 14.12x | $-6.10 Million |
| 2018 | 25.35% | 3.31% | 0.88x | 8.72x | $19.52 Million |
| 2019 | 9.73% | 1.28% | 0.70x | 10.85x | $-412.50K |
| 2020 | -8.95% | -1.38% | 0.60x | 10.78x | $-31.41 Million |
| 2021 | 10.80% | 1.88% | 0.64x | 8.99x | $1.84 Million |
| 2022 | 3.20% | 0.74% | 0.59x | 7.31x | $-22.65 Million |
| 2023 | 0.48% | 0.19% | 0.60x | 4.27x | $-60.03 Million |
| 2024 | 0.31% | 0.15% | 0.56x | 3.64x | $-87.44 Million |
| 2025 | -1.71% | -0.91% | 0.54x | 3.45x | $-127.64 Million |
Industry Comparison
This section compares RadNet Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RadNet Inc (RDNT) | $1.36 Billion | 0.00% | 1.77x | $4.18 Billion |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |